Skip to content
Advertisement

A nurse holds a dose of experimental vaccine "cAd3-EBOZ Lau" at the Lausanne University Hospital (CHUV) in Lausanne, Switzerland, Tuesday, Nov. 4, 2014. Swissmedic approved the application for a trial with an experimental Ebola vaccine at the Lausanne University Hospital (CHUV). It will be conducted on 120 volunteer participants. The trial continues the series that began in the USA, the UK and Mali. The vaccine, based on a genetically modified chimpanzee adenovirus will initially be administered to healthy volunteers who will be deployed as medical staff in the fight against the Ebola epidemic in West Africa. (AP Photo/Keystone,Jean-Christophe Bott)
Photo by: Jean-christophe Bott
A nurse holds a dose of experimental vaccine "cAd3-EBOZ Lau" at the Lausanne University Hospital (CHUV) in Lausanne, Switzerland, Tuesday, Nov. 4, 2014. Swissmedic approved the application for a trial with an experimental Ebola vaccine at the Lausanne University Hospital (CHUV). It will be conducted on 120 volunteer participants. The trial continues the series that began in the USA, the UK and Mali. The vaccine, based on a genetically modified chimpanzee adenovirus will initially be administered to healthy volunteers who will be deployed as medical staff in the fight against the Ebola epidemic in West Africa. (AP Photo/Keystone,Jean-Christophe Bott)

Featured Photo Galleries

01-Army parade.png

Military parade celebrates Army’s 250th

Cheers and chants rang out Saturday from a crowd of thousands as soldiers manned modern and historic tanks and aircraft for the Army’s 250th anniversary celebration in the District.

20250330 Sabatini-Caps-Sabres 001.jpg

Ovi scores goal 890, Caps lose to Sabres 8-5

Alexander Ovechkin scored goal number 890, but the Washington Capitals fell short, losing to the visiting Buffalo Sabres Sunday afternoon 8-5 at Capital One Arena in Washington D.C., March 30, 2025 (Photos for the Washington Times.)